Effects of instillation of eyedrops containing disulfiram and hydroxypropyl-β-cyclodextrin inclusion complex on endotoxin-induced uveitis in rats

Curr Eye Res. 2012 Feb;37(2):124-31. doi: 10.3109/02713683.2011.622853. Epub 2011 Oct 26.

Abstract

Objective: To investigate the anti-inflammatory effects of the instillation of disulfirum (DSF) eyedrops that enhance solubility using 2-hydroxypropyl-β-cyclodextrin (HPβCD) and hydroxypropylmethylcellulose (HPMC) on endotoxin-induced uveitis (EIU) in rats and mechanisms related to ocular inflammation.

Methods: EIU was induced in male Lewis rats by subcutaneous injection of 200 μg lipopolysaccharide (LPS). DSF (0.125%, 0.25% and 0.5%) or commercially available 0.05% dexamethasone (Dexa) was topically applied to both eyes of rats 1 hour before, immediately after, and 1 and 2 hours after injection of LPS. The aqueous humor (AqH) was collected 24 hours after LPS injection, and the number of infiltrating cells, protein concentration, and levels of tumor necrosis factor-α (TNF-α), nitric oxide (NO) and prostaglandin E2 (PGE2) were determined. Immunohistochemical analysis of the iris ciliary body (ICB) cells was performed to determine the expression of activated nuclear factor κB (NF-κB), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2).

Results: The topical administration with DSF suppressed, in a dose-dependent manner, the number of inflammatory cells, the protein concentration, and the levels of NO, TNF-α and PGE2 in the AqH and improved the histologic status of the ocular tissue. The anti-inflammatory potency of 0.5% DSF treatment was as strong as that of 0.05% Dexa. Topical DSF treatment also suppressed the activated NF-κB 3 hours after LPS injection, and iNOS and COX-2 expression in the ICB 24 hours after LPS injection.

Conclusions: The present results demonstrate that the topical instillation of DSF eyedrops suppresses the inflammation in EIU, suggesting a possible novel approach for the treatment of ocular inflammation.

MeSH terms

  • 2-Hydroxypropyl-beta-cyclodextrin
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Aqueous Humor / metabolism
  • Dexamethasone / administration & dosage
  • Dinoprostone / metabolism
  • Disease Models, Animal
  • Disulfiram / administration & dosage*
  • Dose-Response Relationship, Drug
  • Lipopolysaccharides
  • Male
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Ophthalmic Solutions
  • Rats
  • Rats, Inbred Lew
  • Tumor Necrosis Factor-alpha / metabolism
  • Uveitis / chemically induced
  • Uveitis / drug therapy*
  • Uveitis / metabolism
  • beta-Cyclodextrins / administration & dosage*

Substances

  • Anti-Inflammatory Agents
  • Lipopolysaccharides
  • NF-kappa B
  • Ophthalmic Solutions
  • Tumor Necrosis Factor-alpha
  • beta-Cyclodextrins
  • 2-Hydroxypropyl-beta-cyclodextrin
  • Nitric Oxide
  • Dexamethasone
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Dinoprostone
  • Disulfiram